Boston Scientific Corp’s recently made public that its Chairman, President & CEO Mahoney Michael F unloaded Company’s shares for reported $16.45 million on Apr 01 ’25. In the deal valued at $100.01 per share,164,442 shares were sold. As a result of this transaction, Mahoney Michael F now holds 1,594,530 shares worth roughly $143.03 million.
Then, MICHAEL F MAHONEY bought 164,442 shares, generating $16,445,068 in total proceeds.
Before that, Brown Vance R sold 4,826 shares. Boston Scientific Corp shares valued at $486,702 were divested by the SVP, GC and Corp. Secretary at a price of $100.85 per share. As a result of the transaction, Brown Vance R now holds 41,019 shares, worth roughly $3.68 million.
Deutsche Bank upgraded its Boston Scientific Corp [BSX] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Needham’s analysts, who decreased its forecast for the stock in mid October from “a Buy” to “a Hold”. Goldman began covering BSX with “Buy” recommendation on May 30, 2024. Mizuho revised its rating on February 01, 2024. It rated BSX as “a Buy” which previously was an “a Neutral”.
Price Performance Review of BSX
On Friday, Boston Scientific Corp [NYSE:BSX] saw its stock fall -8.93% to $89.70. Over the last five days, the stock has lost -9.72%. Boston Scientific Corp shares have risen nearly 0.43% since the year began. Nevertheless, the stocks have risen 31.66% over the past one year. While a 52-week high of $107.17 was reached on 02/05/25, a 52-week low of $66.80 was recorded on 01/02/25. SMA at 50 days reached $101.80, while 200 days put it at $88.63.
Levels Of Support And Resistance For BSX Stock
The 24-hour chart illustrates a support level at 87.60, which if violated will result in even more drops to 85.51. On the upside, there is a resistance level at 93.84. A further resistance level may holdings at 97.99. The Relative Strength Index (RSI) on the 14-day chart is 28.38, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -3.97, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 99.66%. Stochastics %K at 25.57% indicates the stock is a holding.
How much short interest is there in Boston Scientific Corp?
A steep rise in short interest was recorded in Boston Scientific Corp stocks on 2025-03-14, growing by 1.17 million shares to a total of 12.62 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 11.46 million shares. There was a rise of 9.25%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 19, 2023 when Robert W. Baird began covering the stock and recommended ‘”an Outperform”‘ rating along with a $59 price target.
